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Abstract
© 2015 the American Physiological  Society Fibroblast  growth factors (Fgfs)  mediate organ
repair. Lung epithelial cell overexpression of Fgf10 postbleomycin injury is both protective and
therapeutic,  characterized  by  increased  survival  and  attenuated  fibrosis.  Exogenous
administration of FGF7 (palifermin) also showed prophylactic survival benefits in mice. The role
of endogenous Fgfr2b ligands on bleomycin-induced lung fibrosis is still  elusive. This study
reports the expression of endogenous Fgfr2b ligands, receptors, and signaling targets in wild-
type mice following bleomycin lung injury. In addition, the impact of attenuating endogenous
Fgfr2b-ligands following bleomycin-induced fibrosis was tested by using a doxycycline (dox)-
based inducible,  soluble,  dominant-negative form of  the Fgfr2b receptor.  Double-transgenic
(DTG) Rosa26rtTA/+;tet(O)solFgfr2b mice were validated for the expression and activity of soluble
Fgfr2b (failure to regenerate maxillary incisors,  attenuated recombinant FGF7 signal in the
lung). As previously reported, no defects in lung morphometry were detected in DTG (+dox)
mice exposed from postnatal days (PN) 1 through PN105. Female single-transgenic (STG) and
DTG mice were subjected to various levels of bleomycin injury (1.0, 2.0, and 3.0 U/kg). Fgfr2b
ligands were attenuated either throughout injury (days 0-11; days 0-28) or during later stages
(days 6-28 and 14-28). No significant changes in survival, weight, lung function, confluent areas
of fibrosis, or hydroxyproline deposition were detected in DTG mice. These results indicate that
endogenous Fgfr2b ligands do not significantly protect against bleomycin injury, nor do they
expedite the resolution of bleomycin-induced lung injury in mice.
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